Navarra – May 10, 2023 – Medibiofarma S.L., a clinical-stage biotechnology company developing aportfolio of new therapies for the treatment of gastrointestinal (GI) diseases as well as othercancer and non-cancer diseases announced the first patient dosed in the Phase II clinical trial ofMBF-118...